• Sanpower Group to Acquire Dendreon from Valeant for $819.9M americanpharmaceuticalreview
    January 11, 2017
    Sanpower Group, one of the largest privately owned conglomerates in China, reached an agreement with Valeant, a world's leading pharmaceutical company, to acquire a 100% stake in its US biopharmaceutical company Dendreon for $819.9 million.
PharmaSources Customer Service